相关实验视频
Updated: Jan 18, 2026

07:47
Measuring Delay Discounting in Humans Using an Adjusting Amount Task
Published on: January 9, 2016
16.0K
奖励大小特定的延迟折扣区分了躁狂与抑郁症的风险
Robert Raeder1, Manan Arora2, Michele Bertocci2
1Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, University of Pittsburgh, Robert Raeder, 121 Meyran Avenue, Pittsburgh, PA, #20615213, USA. raederr@upmc.edu.
Cognitive, affective & behavioral neuroscience
|May 28, 2025
概括
延迟折扣,即冲动性的衡量标准,可以区分双相情感障碍 (BD) 和非BD个体. 这种行为标志物有助于区分躁狂/低躁狂风险与双相情感障碍患者的抑郁风险.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 行为经济学是一种行为经济学.
背景情况:
- 躁狂/低躁狂是双相情感障碍 (BD) 的核心特征,涉及到强烈的冲动性.
- 延迟折扣,评估对即时奖励的偏好,是冲动性的关键指标.
- 目前尚不清楚延迟折扣是否能将BD与非BD区分开来,或预测情绪发作风险.
研究的目的:
- 为了确定延迟折扣是否区分了BD患者与没有BD患者.
- 为了研究延迟折扣作为躁狂/催眠症与抑郁症风险的行为标记.
主要方法:
- 招募了40名BD患者和187名非BD患者.
- 分层的非BD参与者进入躁狂/低躁狂和抑郁症的风险.
- 使用27项货币选择问卷评估延迟贴现率 (k值).
- 使用Kruskal-Wallis和Dunn的测试分析了数据.
主要成果:
- 在躁狂/低躁狂和抑郁症风险组中,发现延迟折扣率 (k值) 的显著群体差异.
- 对中等奖励大小的延迟折扣显著区分了BD与非BD个人.
- 基于对中等奖励的延迟折扣,将高躁狂/低躁狂风险与抑郁风险区分开来.
结论:
- 延迟折扣,特别是对于中等奖励大小,可以作为一个客观的行为标记.
- 这种标志物可以区分双相情感障碍和非双相情感个人.
- 它还区分了躁狂/低躁狂和抑郁风险,有助于风险检测.
相关概念视频
Bipolar Disorder
634
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
634
Mania and Antimanic Drugs: Overview
561
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
561
Depressive Disorders: MDD and Dysthymia
681
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
681
Depressive Disorders: Etiology
451
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
451
Antidepressant Drugs: MAOIs and Other Agents
831
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
831
Attention-Deficit/Hyperactivity Disorder
792
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
792

